How has Arcus Biosciences's accrued research and development changed year-over-year?

Arcus Biosciences's accrued research and development increased by 78.8% year-over-year, from $52M to $93M.

What is the long-term trend for Arcus Biosciences's accrued research and development?

Over 5 years (2020 to 2025), Arcus Biosciences's accrued research and development has grown at a 37.2% compound annual growth rate (CAGR), from $18.31M to $89M.

Arcus Biosciences RCUS Accrued research and development

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.62B+226%

Enterprise value$3.53B+275%

P/S15.4×+7.5×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept rcus:AccruedResearchAndDevelopmentExpensesCurrent.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's accrued research and development.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's accrued research and development?: Arcus Biosciences (RCUS) reported accrued research and development of $93M in Q1 2026.
How has Arcus Biosciences's accrued research and development changed year-over-year?: Arcus Biosciences's accrued research and development increased by 78.8% year-over-year, from $52M to $93M.
What is the long-term trend for Arcus Biosciences's accrued research and development?: Over 5 years (2020 to 2025), Arcus Biosciences's accrued research and development has grown at a 37.2% compound annual growth rate (CAGR), from $18.31M to $89M.